SAN DIEGO (AP) _ Neurocrine Biosciences Inc. (NBIX) on Monday reported a loss of $41.8 million in its first quarter. On a per-share basis, the San Diego-based company said it had a loss of 47 cents. The results missed Wall Street expectations. The average estimate of eight analysts surveyed by…
News
- Neurocrine: 1Q Earnings Snapshot
- Trump's threats on trade unsettle farming, ranching backers
Trump's victory paid off for farmers and ranchers in the form of rollbacks of environmental regulations imposed during the Obama administration that farmers and ranchers considered burdensome, including ones that could affect irrigation ditches, biotechnology and pesticides. Trump's tactics on…
- 10 more charged with fentanyl dealing that led to overdoses
The Treasury Department also has sanctioned the five Chinese nationals, including Zhang and his biotechnology company. Any assets in which they have an interest must be reported to the department, which is meant to prevent them from doing business with anyone in the U.S. It's the first time the…
- More people charged in international fentanyl operation
Sessions says the Treasury Department also has sanctioned the five Chinese nationals, including the man alleged to be the conspiracy leader, along with his biotechnology company. Any assets in which they have an interest must be reported to the department. It's the first time the department has…
- 10 more charged with fentanyl dealing that led to overdoses
FARGO, N.D. (AP) — U.S. prosecutors said Friday they have charged 10 more people in an international fentanyl trafficking operation that led to overdose deaths in four states. The new indictments bring the total number to 32 people accused of dealing large amounts of the powerful opioid in the U…